Professor of Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy Pittsburgh, Pennsylvania
Disclosure(s): SCCM: Advisory Board (Ongoing)
Disclosure(s):
Sandra L. Kane-Gill, MSc, PharmD, FCCP: SCCM: Advisory Board (Ongoing)
Propose and justify a standardized approach to identifying and evaluating nephrotoxicity for clinical and research purposes that attends to the complexity of the critical care population.
Presentations in this session: The Med, the Myth, the Legend - Ankit Sakhuja, MBBS - CONGRESS DIGITAL ONLY What's in a name: Standardizing nomenclature for nephrotoxicity - Sandra Kane-Gill, MS, PharmD The next frontier in drug stewardship: Nephrotoxins - Erin Barreto, MSc, PharmD, FCCM
